Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53

V. R. Katkoori, K. Manne, V. S. Vital-Reyes, C. Rodríguez-Burford, C. Shanmugam, M. Sthanam, U. Manne, C. Chatla, S. A. Abdulkadir, W. E. Grizzle*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53'. Together they form a unique fingerprint.

Medicine & Life Sciences